PPARG and neoplasm: Derivatives of itaconate that are lipid soluble, including 4-octyl itaconate (OI) and dimethyl itaconate (DI), exerted tumor-enhancing effects that were associated with poor patient survival by downregulating PPARγ, with OI having a slightly higher impact.